Answers are grounded in this paper and cite their sources.
Ocular surface squamous neoplasia (OSSN) encompasses a spectrum of dysplastic and neoplastic lesions affecting the conjunctiva and cornea, often resulting in significant visual morbidity. This case report describes a 74-year-old farmer with a history of previously treated OSSN who presented with recurrence after 3 years. The lesion was successfully treated with perilesional and topical interferon alpha-2b (IFNα2b), without the need for any surgical intervention. A remarkable reduction in the tumor size was seen at 3 months, with complete clinical resolution and visual improvement by 10 months. The patient remained recurrence-free over a follow-up period of 3 years. This study highlights the efficacy of IFNα2b monotherapy as a first-line therapeutic option for recurrent OSSN, offering a noninvasive alternative to surgical excision, while ensuring remission and preservation of vision.
No takes yet. Share an insight, caveat, or question.
Dubbaka et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: